On Monday, the FDA declined Invivyd, Inc.’s (NASDAQ:IVVD) request to expand the existing emergency use authorization (EUA) for pre-exposure prophylaxis of COVID-19 EUA for Pemgarda (pemivibart) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback